Sign in
4

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001415889-24-024899

Director sold 2,825 shares at $27.51 ($77,704)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Heyman Richard A. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-10-04 Sale : show line 1 in the form 10b5-1 −2,825 $27.51 $77,704 125,760 D
Open-market sales · 2,825 sh · avg $27.51 · $77,704
Loading xslF345X05/form4-10082024_101045.xml…